Lwm Advisory Services, LLC Astrazeneca PLC Transaction History

Lwm Advisory Services, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 02, 2023	BUY	$64.85 - $71.7 $33,332 - $36,853	514 New	514 $34,000
Q4 2022 Feb 07, 2023	SELL	$54.21 - $70.44 $126,417 - $164,266	-2,332 Reduced 32.6%	4,822 $326,000
Q3 2022 Nov 16, 2022	SELL	$53.02 - $135.75 $3,711 - $9,502	-70 Reduced 0.97%	7,154 $392,000
Q2 2022 Aug 15, 2022	BUY	$59.26 - $71.14 $1,303 - $1,565	22 Added 0.31%	7,224 $477,000
Q1 2022 May 09, 2022	SELL	$55.72 - $67.12 $5,237 - $6,309	-94 Reduced 1.29%	7,202 $478,000
Q4 2021 Feb 18, 2022	BUY	$54.02 - $63.83 $394,129 - $465,703	7,296 New	7,296 $425,000

1,335

476M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $221B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Lwm Advisory Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Lwm Advisory Services, LLC with notifications on news.